Titan Pharmaceuticals Reports First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. NVDA
6. MSFT
7. SPY
8. SKYD
9. CRWV
10. CRBU

Go back to Titan Pharmaceuticals Reports First Quarter 2020 Financial Results

Titan Pharma (TTNP) Reports Q1 Loss of $0.07

May 15, 2020 9:06 AM EDT

Titan Pharma (NASDAQ: TTNP) reported Q1 EPS of ($0.07), versus ($0.34) reported last year.

First Quarter 2020 Highlights

In January 2020, Titan completed an offering resulting in net cash proceeds of approximately $1.9 million.Since January 1, 2020, the Company received proceeds of approximately $6.7 million as a result of the exercise of previously issued common stock purchase warrants.

COVID-19 Impact and Adjusted Probuphine Commercial Strategy

Titan's commercial operations expansion has continued throughout the past several months, with additions to its sales and medical liaison teams, including support from additional marketing and medical access staff, that... More